The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
Public rejection of "cloned" beef may seem like a knee-jerk reaction to a loaded work. But biotech has a problem that isn't going away.
It seems like only yesterday that Alfred Vellucci, the crusty mayor of Cambridge, Mass. during the 1970s and self-styled one-man poison pill to the burgeoning biotech industry, hauled the cloners of Harvard and MIT before the city council and gave them a lesson in English 101. "Most of
us in this room, including myself, are lay people," he solemnly intoned during an infamous June 1976 meeting, during which the burghers debated a moratorium on experiments using recombinant DNA. "We don't understand your alphabet. So you will spell it out for us so we'll know exactly what you're talking about..."
A scientist stripped of jargon, it must be said, offers a particularly forlorn form of public nakedness. Although I never found Vellucci's scientific arguments against recombinant DNA very convincing, I have always had a grudging admiration for the populist economy with which he revised the terms of the debate. He displayed an artful ability to see that a common vocabulary was essential to resolving (or, in this case, roiling) public debate about a new technology.
To read the entire article you must log in:
Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
Our list of the 50 most innovative companies, including the following: